Fund shareholders of Ovid therapeutics Inc
ISIN US6904691010 · United States · LEI 549300H36NUI4L6U8F17
- Fund shareholders
- 21
- Of which ETFs
- 5 16 other funds
- Value held
- 26.6M $
- Share of capital
- 5.9 % of 195.3M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,829,016 | 8.5M $ | 0.00 % | 1.96 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2,895,593 | 6.4M $ | 0.40 % | 1.48 % | as of Mar 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 2,380,666 | 6.6M $ | 0.23 % | 1.22 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,330,202 | 3M $ | 0.00 % | 0.68 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 320,743 | 522.8K $ | 0.00 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 130,813 | 290.4K $ | 0.42 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 112,670 | 183.7K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 82,602 | 134.6K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 72,000 | 199.4K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 66,483 | 147.6K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 58,053 | 160.8K $ | 0.01 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 37,116 | 60.5K $ | 0.43 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 36,702 | 101.7K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 32,545 | 72.2K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 32,509 | 90K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 31,199 | 50.9K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 13,166 | 36.5K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 6,364 | 17.6K $ | 0.34 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 3,200 | 7.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,583 | 3.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 635 | 1.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.43 % | as of Feb 28, 2026 ↗ |
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 0.42 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.40 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.34 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.23 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 21 | +8 | 11,473,860 | +52.6 % |
| 2026Q1 | 13 | +2 | 7,519,255 | +148.3 % |
| 2025Q4 | 11 | -21 | 3,028,199 | -27.7 % |
| 2025Q3 | 32 | -40 | 4,186,647 | -47.7 % |
| 2025Q2 | 72 | -8 | 8,001,961 | -3.2 % |
| 2025Q1 | 80 | -1 | 8,263,107 | -5.7 % |
| 2024Q4 | 81 | -14 | 8,765,277 | +1.8 % |
| 2024Q3 | 95 | -9 | 8,613,244 | -4.3 % |
| 2024Q2 | 104 | +9 | 8,999,589 | -1.5 % |
| 2024Q1 | 95 | +1 | 9,141,157 | +8.6 % |
| 2023Q4 | 94 | 8,417,558 |
Institutional managers
100 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10,714,000 | 23.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 10,714,000 | 23.7M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 10,636,318 | 23.6M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 9,916,911 | 22M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,163,781 | 13.7M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 5,533,073 | 12.3M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 4,544,113 | 10.1M $ | as of Mar 31, 2026 |
| Saturn V Capital Management LP | 4,166,666 | 9.2M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 3,571,000 | 7.9M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 2,894,704 | 6.4M $ | as of Mar 31, 2026 |
| Ally Bridge Group (NY) LLC | 2,818,459 | 6.3M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,947,594 | 4.3M $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 1,904,666 | 4.2M $ | as of Mar 31, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 1,622,828 | 3.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,533,283 | 3.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,496,518 | 3.3M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,320,610 | 2.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,318,091 | 2.9M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,256,869 | 2.8M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 1,252,381 | 2.8M $ | as of Mar 31, 2026 |
| Rosalind Advisors, Inc. | 1,107,994 | 2.5M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,104,300 | 2.5M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | 2.2M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 927,913 | 2.1M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 921,457 | 2M $ | as of Mar 31, 2026 |
Declared shareholders of Ovid therapeutics Inc
There are 6 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sirenia Capital Management LP and 1 other | 9.90 % | 18,031,333 | as of Mar 31, 2026 · SCHEDULE 13G |
| Affinity Asset Advisors, LLC and 1 other | 9.10 % | 15,635,484 | as of Mar 31, 2026 · SCHEDULE 13G |
| Eventide Asset Management, LLC and 2 others | 7.30 % | 12,773,577 | as of Mar 31, 2026 · SCHEDULE 13G |
| Balyasny Asset Management L.P. and 4 others | 5.33 % | 7,029,223 | as of Mar 31, 2026 · SCHEDULE 13G |
| Jeremy M. Levin | 4.50 % | 8,551,502 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 1.30 % | 1,903,943 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Ovid therapeutics Inc". https://titelia.com/en/stocks/ovid-therapeutics-inc-US6904691010